Capital Induction Inc.

Santarus to Present at Lazard Capital Markets 6th Annual Healthcare Conference.(Conference news)
Business Wire; 11/10/2009; 845 words; ...SAN DIEGO -- Santarus, Inc. (NASDAQ:SNTS...presentation at the Lazard Capital Markets 6th Annual Healthcare...About Santarus Santarus, Inc. is a specialty biopharmaceutical...clinical trials for the induction of remission of mild or...trademarks of Santarus, Inc. GLUMETZA([R] )is...

Vion Pharmaceuticals Reports 2009 Third Quarter and Nine-Month Results.
PR Newswire; 11/10/2009; 1853 words; ...VION PHARMACEUTICALS, INC. (BULLETIN BOARD...Vion Pharmaceuticals, Inc. is committed to extending...TM) for remission induction treatment for patients...assets, and raising new capital, in which case it may...the inability to access capital and funding on favorable...

Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences.
Business Wire; 11/6/2009; 966 words; ...company has acquired from Gilead Sciences, Inc. the worldwide license, including related...cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death...manages more than $8 billion of equity capital invested in a wide range of companies...

Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1091 words; ...collaboration with Symphony Capital LLC, has initiated a...Altus Pharmaceuticals Inc., of Cambridge, Mass...IND. o Array BioPharma Inc., of Boulder, Colo...Avalon Pharmaceuticals Inc., of Germantown, Md...pharmacokinetics and an induction of biomarkers associated...

Genzyme Wants AnorMed For $380M; AnorMed Uninterested.
BIOWORLD Today; 11/3/2009; 1195 words; Staff Writer After AnorMed Inc.'s board rejected an unsolicited...take advantage of the fact that capital markets for small-cap biotechs...of Zacks Investment Research Inc. in Chicago, told BioWorld...countries outside the U.S. for induction therapy prior to solid organ...